| 注册
首页|期刊导航|中国药业|低分子肝素治疗进展型脑梗死22例

低分子肝素治疗进展型脑梗死22例

朱亚兰

中国药业2011,Vol.20Issue(15):67-68,2.
中国药业2011,Vol.20Issue(15):67-68,2.

低分子肝素治疗进展型脑梗死22例

Low Molecular Heparin for Treating Acute Progressing Cerebral Infarction in 22 Cases

朱亚兰1

作者信息

  • 1. 四川省广汉市人民医院神经内科,四川,广汉,618300
  • 折叠

摘要

Abstract

Objective To investigate the curative effect of low molecular heparin in the treatment of acute progressing cerebral infarction.Methods Forty- seven cases of acute progressing cerebral infarction in our hospital from March,2008 to August,2010 were selected and randomly divided into two groups. Tweenty- two cases in the treatment group were treated by subcutaneous injection of 5 000 units low molecular heparin once every 12 h and oral aspirin 100 mg once daily for successive 7 d. Those in the control group were treated by oral aspirin 100 mg once daily alone. The curative effect was evaluated by observing the improvement of patients' neurological deficit symptoms and the score of neurological deficit. Results The stop and improvement of patients' neurological deficit symptoms in the treatment group were significantly better than those in the control group (P < 0. 01). Conclusion Low molecular heparin can stop the disease progression and improve the neurological deficits effectively with less adverse reactions.

关键词

低分子肝素/进展型脑梗塞/疗效

Key words

low molecular heparin/ progressing cerebral infarction/ curative effect

分类

医药卫生

引用本文复制引用

朱亚兰..低分子肝素治疗进展型脑梗死22例[J].中国药业,2011,20(15):67-68,2.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文